Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAngiodynamic Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$0.11 | -$0.10 | -$0.10 |
| Q2 2026 | 2 | -$0.12 | -$0.06 | -$0.09 |
| Q3 2026 | 2 | -$0.11 | -$0.08 | -$0.10 |
| Q4 2026 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q1 2027 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q2 2027 | 1 | $0.01 | $0.01 | $0.01 |
Angiodynamic Inc Earnings Date And Information
Angiodynamic Inc last posted its earnings results on Thursday, April 2nd, 2026. The company reported $-0.07 earnings per share for the quarter, topping analysts' consensus estimates of $-0.11 by $0.04. The company had revenue of 78.42 M for the quarter and had revenue of 292.50 M for the year. Angiodynamic Inc has generated $-1 earnings per share over the last year ($-0.83 diluted earnings per share) and currently has a price-to-earnings ratio of -14.37. Angiodynamic Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Angiodynamic Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/02/2026 | Q3 2026 | -$0.11 | -$0.19 | -0.08 | $76.77 M | $78.42 M |
| 01/06/2026 | Q2 2026 | -$0.10 | -$0.15 | -0.05 | N/A | $79.43 M |
| 10/02/2025 | Q1 2026 | -$0.14 | -$0.26 | -0.12 | N/A | $75.71 M |
| 07/18/2025 | Q4 2025 | N/A | -$0.15 | N/A | N/A | $80.16 M |
| 04/02/2025 | Q3 2025 | -$0.13 | -$0.11 | 0.02 | $70.30 M | $72.00 M |
| 01/08/2025 | Q2 2025 | -$0.11 | -$0.26 | -0.15 | N/A | $72.85 M |
| 10/03/2024 | Q1 2025 | -$0.15 | -$0.31 | -0.16 | N/A | $67.49 M |
| 07/25/2024 | Q4 2024 | N/A | -$0.33 | N/A | N/A | $70.98 M |
| 04/09/2024 | Q3 2024 | N/A | -$4.67 | N/A | $132.66 M | $75.18 M |
| 01/08/2024 | Q2 2024 | N/A | -$0.72 | N/A | $143.14 M | $79.07 M |
| 10/05/2023 | Q1 2024 | N/A | $1.15 | N/A | N/A | $78.68 M |
| 08/03/2023 | Q4 2023 | N/A | -$0.54 | N/A | N/A | $91.07 M |
| 03/31/2023 | Q3 2023 | N/A | -$0.24 | N/A | N/A | $80.71 M |
| 01/06/2023 | Q2 2023 | N/A | -$0.21 | N/A | N/A | $85.43 M |
| 10/11/2022 | Q1 2023 | N/A | -$0.33 | N/A | N/A | $81.54 M |
| 07/22/2022 | Q4 2022 | N/A | -$0.16 | N/A | N/A | $87.00 M |
| 04/07/2022 | Q3 2022 | $0.01 | -$0.13 | -0.14 | N/A | $73.97 M |
| 01/07/2022 | Q2 2022 | N/A | -$0.21 | N/A | N/A | $78.28 M |
| 09/30/2021 | Q1 2022 | -$0.05 | -$0.18 | -0.13 | N/A | $76.97 M |
| 07/27/2021 | Q4 2021 | N/A | -$0.51 | N/A | N/A | $76.84 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Angiodynamic Inc Earnings: FAQ's
In the previous quarter, Angiodynamic Inc (:ANGO) reported $-0.07 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.11 by $0.04.
The conference call for Angiodynamic Inc's latest earnings report can be listened to online.
The conference call transcript for Angiodynamic Inc's latest earnings report can be read online.
Angiodynamic Inc (:ANGO) has a recorded annual revenue of $292.50 M.
Angiodynamic Inc (:ANGO) has a recorded net income of $-33,993,000.Angiodynamic Inc has generated $-0.83 earnings per share over the last four quarters.
Angiodynamic Inc (:ANGO) has a price-to-earnings ratio of -14.37 and price/earnings-to-growth ratio is -0.56.